• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL NAVITOR TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL NAVITOR TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Catalog Number NVTR-25
Device Problems Difficult to Fold, Unfold or Collapse (1254); Perivalvular Leak (1457); Off-Label Use (1494); Patient Device Interaction Problem (4001)
Patient Problems Stroke/CVA (1770); Perforation (2001)
Event Date 01/29/2024
Event Type  Death  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The date of death is estimated to (b)(6) 2024, as this is when we received the information.
 
Event Description
It was reported that on (b)(6) 2024, a 27mm navitor valve was chosen for implantation into a bicuspid aortic valve anatomy type 1 utilizing an unknown flexnav delivery system.The patient presented with severe calicum score of 6251, severe aortic stenosis, and horizontal aorta.The valve was pre-dilated with a 18mm balloon ((balloon annular valvuloplasty (bav)).A guidewire and a buddy wire was needed to traverse the difficult horizontal aorta.At deployment, the navitor was placed at 5mm in left coronary cusp (lcc), 4mm in non-coronary cusp (ncc), and 5mm in right coronary cusp (rcc).After full release, the 27mm navitor was at 5mm in lcc, 4 mm in ncc and 6mm in rcc.No tension in delivery system during deployment.The valve looked constrained due to the severe calcification and moderate perivalvular leak (pvl) was present.Post-bav dilatation was performed with a 20mm balloon.Once the balloon was removed, the navitor migrated supra annular.There was no blocking of coronary arteries and no clinical signs or symptoms due to the migration.The valve was snared and placed 5 cm above the aortic annulus.A replacement 25mm navitor (serial:(b)(6)) was then implanted.Due to valve under expansion, post-bav dilatation was performed with 20mm balloon seven times.Gradient of 13mmhg.The procedure ended with mild pvl present on echocardiogram.There was reportedly a delay that resulted in no patient effects.The patient is reported to be recovering in rehabilitation unit.Post procedure, the patient suffered a multi territory stroke.Computerized tomagraphy scan was taken revealing an aortic dissection in the ascending aorta.It was thought this dissection was due to snaring the migrated valve.It was thought the stroke was related to multiple balloon valvuloplasty's, valve post-dilatations and crossing aortic valve difficult horizontal angle.The patient died on an unknown date.The cause of death is unknown.
 
Event Description
It was reported that on (b)(6) 2024, a 27mm navitor valve was chosen for implantation into a bicuspid aortic valve anatomy type 1 utilizing a flexnav delivery system.The patient presented with severe calicum score of 6251, severe aortic stenosis, and horizontal aorta.The valve was pre-dilated with a 18mm balloon ((balloon annular valvuloplasty (bav)).A guidewire and a buddy wire was needed to traverse the difficult horizontal aorta.At deployment, the navitor was placed at 5mm in left coronary cusp (lcc), 4mm in non-coronary cusp (ncc), and 5mm in right coronary cusp (rcc).After full release, the 27mm navitor was at 5mm in lcc, 4 mm in ncc and 6mm in rcc.No tension in delivery system during deployment.The valve looked constrained due to the severe calcification and moderate perivalvular leak (pvl) was present.Post-bav dilatation was performed with a 20mm balloon.Once the balloon was removed, the navitor migrated supra annular.There was no blocking of coronary arteries and no clinical signs or symptoms due to the migration.The valve was snared and placed 5 cm above the aortic annulus.A replacement 25mm navitor (serial:(b)(6)) was then implanted.Due to valve under expansion, post-bav dilatation was performed with 20mm balloon seven times.Gradient of 13mmhg.The procedure ended with mild pvl present on echocardiogram.There was reportedly a delay that resulted in no patient effects.Post procedure, after removal from general anesthesia, the patient was confused and having trouble waking up.Computerized tomography scan was taken which also revealed multi territory stroke as well as aortic dissection in the ascending aorta.It was thought this dissection was due to snaring the migrated valve along with difficulty crossing the horizontal aorta with both flexnav delivery systems.It was thought the stroke was related to both valves causing debris embolization, multiple balloon valvuloplasty's, and difficulty crossing aortic valve due to horizontal angle with both flexnav delivery systems.The patient was not a surgical candidate so they were managed medically.Patient had thrombocytopenia which increased risk of bleeding.The patient died three days post-procedure.The cause of death was due to the aortic dissection and stroke.
 
Manufacturer Narrative
An event of paravalvular leak (pvl), off-label use, valve underexpansion, patient-device interaction problem, and death was reported.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Possible causes for paravalvular leak are sizing of the valve, implant depth, calcium distribution, deployment difficulties and inadequate radial forces.Information from the field indicated that the valve appears to be correctly sized based on provided annular dimensions, there was a significant amount of calcium in the annulus, and there was some difficulty with deployment due to the horizontal aortic valve angle.No information was received regarding implant depth was received.The patient had a bicuspid anatomy, and the valve was implanted after a larger sized valve migrated and was snared.Due to valve under expansion, post-bav (balloon annular valvuloplasty) dilatation was performed with 20mm balloon seven times.Post-procedure, the patient was diagnosed with a multi territory stroke as well as aortic dissection in the ascending aorta.It was thought this dissection was due to snaring the migrated valve along with difficulty crossing the horizontal aorta with both flexnav delivery systems.It was thought the stroke was related to both valves causing debris embolization, multiple balloon valvuloplasty's, and difficulty crossing the aortic valve due to horizontal angle with both flexnav delivery systems.The patient died three days post-procedure.The cause of death was due to the aortic dissection and stroke.The event was further reviewed by an abbott senior director of medical affairs.Based on available information, the reported event appears to be related to a combination of procedural conditions (multiple balloon valvuloplasties, decision to snare other valve, etc.) and patient condition (severe calcification).The reported off-label use is related to the valve being used on a patient with a bicuspid aortic valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVITOR TRANSCATHETER AORTIC VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18743616
MDR Text Key335809907
Report Number2135147-2024-00763
Device Sequence Number1
Product Code NPT
UDI-Device Identifier05415067031587
UDI-Public05415067031587
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P190023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberNVTR-25
Device Lot Number9057210
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/12/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/02/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age89 YR
Patient SexFemale
Patient Weight80 KG
-
-